Compound library storage underpins modern drug discovery, chemical biology, and screening-driven research. It refers to the controlled systems, conditions, and practices used to preserve collections ...
Pharmaceutical companies amass huge libraries of chemical compounds they can test to see if one just might be capable of being developed into a new drug. But what if, even with millions of compounds, ...
Even before companies spend exorbitant amounts on clinical trials (most of which fail), they already have spent significant time and money identifying the best drug candidates for those trials.
Tokyo, Japan – March 19, 2014 – Astellas Pharma Inc. ("Astellas"; Tokyo: 4503; President and CEO: Yoshihiko Hatanaka) and Daiichi Sankyo Company, Limited ("Daiichi Sankyo," President and CEO: Joji ...
Combinatorial chemistry has been widely adopted by the pharmaceutical industry in the past decade. However, owing to perceived “failures” with this technology, the pharmaceutical industry has been ...
Sanofi and AstraZeneca have struck a deal in which they will exchange 210,000 chemicals from their respective compound libraries. The goal is to enhance the diversity of each company’s collection, ...
DUNDEE, Scotland--(BUSINESS WIRE)--Ubiquigent Limited, a company focused on enabling and supporting ubiquitin system-focused drug discovery, announced today that it had entered into an agreement with ...
Potential inhibitors of a target biomolecule, NAD-dependent deacetylase Sirtuin 1, were identified by a contest-based approach, in which participants were asked to propose a prioritized list of 400 ...
Screening libraries will leverage Recursion's MatchMaker tool to identify compounds across Enamine REAL Space predicted to bind to high-value targets. KYIV, Ukraine and SALT LAKE CITY, Dec. 20, 2023 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results